No abstract available
Keywords:
Apomorphine pump; Covid-19; Levodopa; Neuroleptic Malignant Syndrome; Parkinson disease.
MeSH terms
-
Antiparkinson Agents / adverse effects
-
COVID-19 / complications
-
COVID-19 / therapy*
-
Drug Interactions
-
Humans
-
Intensive Care Units
-
Neuroleptic Malignant Syndrome / etiology
-
Nonprescription Drugs / adverse effects
-
Parkinson Disease / complications
-
Parkinson Disease / physiopathology
-
Parkinson Disease / therapy*
-
SARS-CoV-2
-
Self Medication
-
Serotonin Syndrome / chemically induced
Substances
-
Antiparkinson Agents
-
Nonprescription Drugs